Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
Pegylated recombinant human hepatic arginase I (rhArg-peg 5,000 mw) inhibits human hepatocellular carcinoma in vitro and in vivo Proceeding/Conference:The International Meeting of Hepatocellular Carcinoma | 2004 | ||
Remission of hepatocellular carcinoma with Arginine depletion induced by systemic release of endogenous hepatic arginase due to transheaptic embolization augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma Proceeding/Conference:The International Meeting of Hepatocellular Carcinoma | 2004 |